Atlas Trials

A Study to Collect Data on the Treatment Pattern of Xarelto + Acetylsalicylic Acid in the Routine Clinical Practice in Patients Who Are Suffering From a Condition That Narrows the Blood Vessels Supplying the Heart and / or a Condition That Most Commonly Narrows the Blood Vessel in the Legs

Clinical trial NCT04401761 · COMPLETED

Trial details

NCT number
NCT04401761
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
Coronary Artery DiseasePeripheral Artery Disease
Start date
2020-05-28
Primary completion
2023-06-30
Enrollment
3189

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.